Digitally-enhanced medication-assisted treatment for opioid use disorder

Acceptability, engagement and treatment retention

Dados Bibliográficos

ID15519408
AutoresJesús Palacios (0000-0002-2103-5507, Rapt Therapeutics (United States), autor correspondente), Jorge E Palacios, Robert Sherrick (0000-0002-4436-0134, Scottsdale Community College), Sylvie Lorenzen (Rapt Therapeutics (United States)), Sara Lorenzen, Jenna Tregarthen (0000-0002-4787-7059, Rapt Therapeutics (United States))
Ano2025
Volume16
Páginas1581298-1581298
Data de publicação2025-10-02
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoFrontiers in Psychiatry (JOURNAL)
Identificadores do periódicoISSN: 1664-0640 • E-ISSN: 1664-0640
EditoraFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2025.1581298
PMID41113189
OpenAlexW4414765517
IdiomaEN
Referências citadas25

Digital tools such as Recovery Connect show promise in addressing key barriers to MOUD retention by enhancing patient accountability, self-monitoring, and clinician-patient communication. These findings support the integration of digital interventions into standard MOUD care, with future research needed to assess long-term retention and scalability

Data retention · Key (lock · MEDLINE · Opioid · Opioid use disorder · Psychological intervention · Digital Mental Health Interventions · Mobile Health and mHealth Applications · Opioid Use Disorder Treatment